{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:12:28Z","timestamp":1778944348005,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,25]]},"DOI":"10.7759\/cureus.25331","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T19:43:46Z","timestamp":1653507826000},"source":"Crossref","is-referenced-by-count":1,"title":["Oral Malignant Melanoma in a Patient With Neurofibromatosis Type 1: An Extremely Rare Association"],"prefix":"10.7759","author":[{"given":"Soufiane","family":"Berhili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Rezzoug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Ben Sghier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Moukhlissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loubna","family":"Mezouar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0945","article-title":"Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020","volume":"4","author":"Landry JP","year":"2021","unstructured":"Landry JP, Schertz KL, Chiang YJ, et al.. Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020. JAMA Netw Open. 2021, 4:e210945. 10.1001\/jamanetworkopen.2021.0945","journal-title":"JAMA Netw Open"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5070\/D32511046137","article-title":"Melanoma in individuals with neurofibromatosis type 1: A retrospective study","volume":"15","author":"Zhang M","year":"2019","unstructured":"Zhang M, Bhat T, Gutmann DH, Johnson KJ. Melanoma in individuals with neurofibromatosis type 1: A retrospective study. Dermatol Online J. 2019, 15:13030-5. 10.5070\/D32511046137","journal-title":"Dermatol Online J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.33.1.2","article-title":"Molecular genetics of neurofibromatosis type 1 (NF1)","volume":"33","author":"Shen MH","year":"1996","unstructured":"Shen MH, Harper PS, Upadhyaya M. Molecular genetics of neurofibromatosis type 1 (NF1). J Med Genet. 1996, 33:2-17. 10.1136\/jmg.33.1.2","journal-title":"J Med Genet"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2125::AID-CNCR9>3.0.CO;2-N","article-title":"Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population","volume":"79","author":"Z\u00f6ller ME","year":"1997","unstructured":"Z\u00f6ller ME, Rembeck B, Od\u00e9n A, Samuelsson M, Angervall L. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population. Cancer. 1997, 79:2125-2131.","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-009-0036-3","article-title":"Neurofibromatosis type 1 and associated malignancies","volume":"9","author":"Yohay K","year":"2009","unstructured":"Yohay K. Neurofibromatosis type 1 and associated malignancies. Curr Neurol Neurosci Rep. 2009, 9:247-53. 10.1007\/s11910-009-0036-3","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2012.535","article-title":"Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study","volume":"108","author":"Seminog OO","year":"2013","unstructured":"Seminog OO, Goldacre MJ. Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study. Br J Cancer. 2013, 108:193-8. 10.1038\/bjc.2012.535","journal-title":"Br J Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2016.142","article-title":"The NF1 gene in tumor syndromes and melanoma","volume":"97","author":"Kiuru M","year":"2017","unstructured":"Kiuru M, Busam KJ. The NF1 gene in tumor syndromes and melanoma. Lab Invest. 2017, 97:146-57. 10.1038\/labinvest.2016.142","journal-title":"Lab Invest"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-197201000-00015","article-title":"Von Recklinghausen's disease: a clinicopathological study","volume":"175","author":"Brasfield RD","year":"1972","unstructured":"Brasfield RD, Das Gupta TK. Von Recklinghausen's disease: a clinicopathological study. Ann Surg. 1972, 175:86-104. 10.1097\/00000658-197201000-00015","journal-title":"Ann Surg"},{"key":"ref9","article-title":"Neurofibromatosis associated with malignant neurofibromas","volume":"107","author":"Knight WA 3rd","year":"1973","unstructured":"Knight WA 3rd, Murphy WK, Gottlieb JA. Neurofibromatosis associated with malignant neurofibromas. Arch Dermatol. 1973, 107:747-50.","journal-title":"Arch Dermatol"},{"key":"ref10","article-title":"Malignancy in neurofibromatosis","volume":"29","author":"Figini MM","year":"1981","unstructured":"Figini MM, Bestetti G, Valli G. Malignancy in neurofibromatosis. Adv Neurol. 1981, 29:33-56.","journal-title":"Adv Neurol"},{"key":"ref11","article-title":"Increased risk of congenital premalignant melanocytic nevi in neurofibromatosis (abst)","volume":"35","author":"Rubenstein AE","year":"1985","unstructured":"Rubenstein AE, Seitz SC, Wallace S, Aron AM, Lebwohl M. Increased risk of congenital premalignant melanocytic nevi in neurofibromatosis (abst). Neurology. 1985, 35:194.","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198604173141603","article-title":"Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms","volume":"314","author":"S\u00f8rensen SA","year":"1986","unstructured":"S\u00f8rensen SA, Mulvihill JJ, Nielsen A. Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms. N Engl J Med. 1986, 314:1010-5. 10.1056\/NEJM198604173141603","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1086\/320121","article-title":"Mortality in neurofibromatosis 1: an analysis using U.S. death certificates","volume":"68","author":"Rasmussen SA","year":"2001","unstructured":"Rasmussen SA, Yang Q, Friedman JM. Mortality in neurofibromatosis 1: an analysis using U.S. death certificates. Am J Hum Genet. 2001, 68:1110-8. 10.1086\/320121","journal-title":"Am J Hum Genet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/00008390-200404000-00014","article-title":"Cutaneous malignant melanoma and neurofibromatosis type 1","volume":"14","author":"Guillot B","year":"2004","unstructured":"Guillot B, Dalac S, Delaunay M, et al.. Cutaneous malignant melanoma and neurofibromatosis type 1. Melanoma Res. 2004, 14:159-63. 10.1097\/00008390-200404000-00014","journal-title":"Melanoma Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.65.3576","article-title":"Distinctive cancer associations in patients with neurofibromatosis type 1","volume":"34","author":"Uusitalo E","year":"2016","unstructured":"Uusitalo E, Rantanen M, Kallionp\u00e4\u00e4 RA, et al.. Distinctive cancer associations in patients with neurofibromatosis type 1. J Clin Oncol. 2016, 34:1978-86. 10.1200\/JCO.2015.65.3576","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2217\/mmt-2018-0003","article-title":"Combatting mucosal melanoma: recent advances and future perspectives","volume":"5","author":"Tyrrell H","year":"2018","unstructured":"Tyrrell H, Payne M. Combatting mucosal melanoma: recent advances and future perspectives. Melanoma Manag. 2018, 5:MMT11. 10.2217\/mmt-2018-0003","journal-title":"Melanoma Manag"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1622.1999.01497.x","article-title":"Primary mucosal and glans penis melanomas: the Sydney Melanoma Unit experience","volume":"69","author":"Larsson KB","year":"1999","unstructured":"Larsson KB, Shaw HM, Thompson JF, Harman RC, McCarthy WH. Primary mucosal and glans penis melanomas: the Sydney Melanoma Unit experience. Aust N Z J Surg. 1999, 69:121-6. 10.1046\/j.1440-1622.1999.01497.x","journal-title":"Aust N Z J Surg"},{"key":"ref18","article-title":"Oral and cutaneous melanoma: clinical recognition, pathological features and prognostic factors","volume":"17","author":"Balch CM","year":"1980","unstructured":"Balch CM. Oral and cutaneous melanoma: clinical recognition, pathological features and prognostic factors. Ala J Med Sci. 1980, 17:51-5.","journal-title":"Ala J Med Sci"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1987.01660260086020","article-title":"Malignant melanoma of mucous membranes. A clinicopathologic study of 13 cases in Japanese patients","volume":"123","author":"Kato T","year":"1987","unstructured":"Kato T, Takematsu H, Tomita Y, Takahashi M, Abe R. Malignant melanoma of mucous membranes. A clinicopathologic study of 13 cases in Japanese patients. Arch Dermatol. 1987, 123:216-20. 10.1001\/archderm.1987.01660260086020","journal-title":"Arch Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/07357900701781762","article-title":"Extracutaneous malignant melanomas","volume":"26","author":"Hussein MR","year":"2008","unstructured":"Hussein MR. Extracutaneous malignant melanomas. Cancer Invest. 2008, 26:516-34. 10.1080\/07357900701781762","journal-title":"Cancer Invest"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw694","article-title":"The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients","volume":"28","author":"Lian B","year":"2017","unstructured":"Lian B, Cui CL, Zhou L, et al.. The natural history and patterns of metastases from mucosal melanoma: an analysis of 706 prospectively-followed patients. Ann Oncol. 2017, 28:868-73. 10.1093\/annonc\/mdw694","journal-title":"Ann Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0522","article-title":"Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of \ufb01rst metastasis","volume":"21","author":"Kuk D","year":"2016","unstructured":"Kuk D, Shoushtari AN, Barker CA, et al.. Prognosis of mucosal, uveal, acral, nonacral cutaneous, and unknown primary melanoma from the time of \ufb01rst metastasis. Oncologist. 2016, 21:848-54. 10.1634\/theoncologist.2015-0522","journal-title":"Oncologist"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/path.4204","article-title":"Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma","volume":"230","author":"Furney SJ","year":"2013","unstructured":"Furney SJ, Turajlic S, Stamp G, et al.. Genome sequencing of mucosal melanomas reveals that they are driven by distinct mechanisms from cutaneous melanoma. J Pathol. 2013, 230:261-9. 10.1002\/path.4204","journal-title":"J Pathol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-014-4215-3","article-title":"Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases","volume":"22","author":"Seifried S","year":"2015","unstructured":"Seifried S, Haydu LE, Quinn MJ, Scolyer RA, Stretch JR, Thompson JF. Melanoma of the vulva and vagina: principles of staging and their relevance to management based on a clinicopathologic analysis of 85 cases. Ann Surg Oncol. 2015, 22:1959-66. 10.1245\/s10434-014-4215-3","journal-title":"Ann Surg Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.6784","article-title":"Importance of clear resection margins in anorectal malignant melanoma","volume":"97","author":"Nilsson PJ","year":"2010","unstructured":"Nilsson PJ, Ragnarsson-Olding BK. Importance of clear resection margins in anorectal malignant melanoma. Br J Surg. 2010, 97:98-103. 10.1002\/bjs.6784","journal-title":"Br J Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1288\/00005537-199402000-00001","article-title":"Mucosal melanoma of the head and neck: the impact of local control on survival","volume":"104","author":"Lee SP","year":"1994","unstructured":"Lee SP, Shimizu KT, Tran LM, Juillard G, Calcaterra TC. Mucosal melanoma of the head and neck: the impact of local control on survival. Laryngoscope. 1994, 104:121-6. 10.1288\/00005537-199402000-00001","journal-title":"Laryngoscope"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0142(19971015)80:8<1373::aid-cncr3>3.0.co;2-g","article-title":"Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients","volume":"80","author":"Manolidis S","year":"1997","unstructured":"Manolidis S, Donald PJ. Malignant mucosal melanoma of the head and neck: review of the literature and report of 14 patients. Cancer. 1997, 80:1373-86. 10.1002\/(sici)1097-0142(19971015)80:8&lt;1373::aid-cncr3&gt;3.0.co;2-g","journal-title":"Cancer"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9378(98)70320-5","article-title":"Primary vaginal melanoma: thirteen-year disease-free survival after wide local excision and review of recent literature","volume":"178(6)","author":"Buchanan DJ","year":"1998","unstructured":"Buchanan DJ, Schlaerth J, Kurosaki T. Primary vaginal melanoma: thirteen-year disease-free survival after wide local excision and review of recent literature. Am J Obstet Gynecol. 1998, 178(6):1177-84. 10.1016\/s0002-9378(98)70320-5","journal-title":"Am J Obstet Gynecol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0705-0","article-title":"Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients?","volume":"17","author":"Iddings DM","year":"2010","unstructured":"Iddings DM, Fleisig AJ, Chen SL, Faries MB, Morton DL. Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients?. Ann Surg Oncol. 2010, 17:40-4. 10.1245\/s10434-009-0705-0","journal-title":"Ann Surg Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6060(98)70073-X","article-title":"Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center","volume":"124(1)","author":"DeMatos P","year":"1998","unstructured":"DeMatos P, Tyler D, Seigler HF. Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center. Surgery. 1998, 124(1):38-48. 10.1016\/S0039-6060(98)70073-X","journal-title":"Surgery"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1285::AID-CNCR25>3.0.CO;2-P","article-title":"Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival","volume":"86(7)","author":"Ragnarsson-Olding BK","year":"1999","unstructured":"Ragnarsson-Olding BK, Nilsson BR, Kanter-Lewensohn LR, Lagerl\u00a8of B, Ringborg UK. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: predictors of survival. Cancer. 1999, 86(7):1285-93. 10.1002\/(SICI)1097-0142(19991001)86:7&lt;1285::AID-CNCR25&gt;3.0.CO;2-P","journal-title":"Cancer"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.2478\/v10019-010-0008-x","article-title":"Role of radiotherapy in melanoma management","volume":"44","author":"Strojan P","year":"2010","unstructured":"Strojan P. Role of radiotherapy in melanoma management. Radiol Oncol. 2010, 44:1-12. 10.2478\/v10019-010-0008-x","journal-title":"Radiol Oncol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2007.07.001","article-title":"What is the role of radiotherapy in the treatment of mucosal melanoma of the head and neck?","volume":"65","author":"Krengli M","year":"2008","unstructured":"Krengli M, Jereczek-Fossa BA, Kaanders JH, Masini L, Beld\u00ec D, Orecchia R. What is the role of radiotherapy in the treatment of mucosal melanoma of the head and neck?. Crit Rev Oncol Hematol. 2008, 65:121-8. 10.1016\/j.critrevonc.2007.07.001","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-6-64-218","article-title":"Classification of tumours in relation to radiosensitivity","volume":"6","author":"Paterson R","year":"1933","unstructured":"Paterson R. Classification of tumours in relation to radiosensitivity. Br J Radiol. 1933, 6:218-33. 10.1259\/0007-1285-6-64-218","journal-title":"Br J Radiol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20092","article-title":"Estimation of an optimal radiotherapy utilization rate for melanoma: a review of the evidence","volume":"100","author":"Delaney G","year":"2004","unstructured":"Delaney G, Barton M, Jacob S. Estimation of an optimal radiotherapy utilization rate for melanoma: a review of the evidence. Cancer. 2004, 100:1293-301. 10.1002\/cncr.20092","journal-title":"Cancer"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1053\/clon.2001.9221","article-title":"The role of biologically effective dose (BED) in clinical oncology","volume":"13","author":"Jones B","year":"2001","unstructured":"Jones B, Dale RG, Deehan C, Hopkins KI, Morgan DA. The role of biologically effective dose (BED) in clinical oncology. Clin Oncol (R Coll Radiol). 2001, 13:71-81. 10.1053\/clon.2001.9221","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90053-7","article-title":"Fraction size in external beam radiation therapy in the treatment of melanoma","volume":"20","author":"Sause WT","year":"1991","unstructured":"Sause WT, Cooper JS, Rush S, et al.. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys. 1991, 20:429-32. 10.1016\/0360-3016(91)90053-7","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref38","article-title":"Role of radiotherapy in the primary management of mucosal melanoma of the head and neck","volume":"9","author":"Trotty A","year":"1993","unstructured":"Trotty A, Peters LJ. Role of radiotherapy in the primary management of mucosal melanoma of the head and neck. Semin Surg Oncol. 1993, 9:246-50.","journal-title":"Semin Surg Oncol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2006.01.016","article-title":"Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A Rare Cancer Network study","volume":"65","author":"Krengli M","year":"2006","unstructured":"Krengli M, Masini L, Kaanders JH, et al.. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A Rare Cancer Network study. Int J Radiat Oncol Biol Phys. 2006, 65:751-9. 10.1016\/j.ijrobp.2006.01.016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2010.217","article-title":"Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study","volume":"136","author":"Benlyazid A","year":"2010","unstructured":"Benlyazid A, Thariat J, Temam S, et al.. Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study. Arch Otolaryngol Head Neck Surg. 2010, 136:1219-25. 10.1001\/archoto.2010.217","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26088","article-title":"Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: a 20-year experience","volume":"117","author":"Kelly P","year":"2011","unstructured":"Kelly P, Zagars GK, Cormier JN, Ross MI, Guadagnolo BA. Sphincter-sparing local excision and hypofractionated radiation therapy for anorectal melanoma: a 20-year experience. Cancer. 2011, 117:4747-55. 10.1002\/cncr.26088","journal-title":"Cancer"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-016-2245-x","article-title":"Rectal melanoma: epidemiology, prognosis, and role of adjuvant radiation therapy","volume":"142","author":"Tchelebi L","year":"2016","unstructured":"Tchelebi L, Guirguis A, Ashamalla H. Rectal melanoma: epidemiology, prognosis, and role of adjuvant radiation therapy. J Cancer Res Clin Oncol. 2016, 142:2569-75. 10.1007\/s00432-016-2245-x","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/96919-oral-malignant-melanoma-in-a-patient-with-neurofibromatosis-type-1-an-extremely-rare-association","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:41:03Z","timestamp":1707507663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/96919-oral-malignant-melanoma-in-a-patient-with-neurofibromatosis-type-1-an-extremely-rare-association"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.25331","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,25]]}}}